F. Carabantes

A Single-Nucleotide Polymorphism in the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor Letrozole in Advanced Breast Carcinoma

Rámón Colomer, Mariano Monzó, Ignasi Tusquets et al. · Clinical Cancer Research · 2008 · 122 citations

A Carboxylesterase 2 Gene Polymorphism as Predictor of Capecitabine on Response and Time to Progression

Nuria Ribelles, J. Lopez-Siles, A. Bartolomé Sánchez et al. · Current Drug Metabolism · 2008 · 69 citations · Full text

Chemoprevention Strategy, Genetics, Pathology +16

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

Miguel Martín, Manuel Ruíz Borrego, Agustí Barnadas et al. · Journal of Clinical Oncology · 2013 · 56 citations · Full text

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer

N. Batista, G. Pérez-Manga, Manuel Constenla et al. · British Journal of Cancer · 2004 · 48 citations · Full text

Phase II COLET study: Atezolizumab (A) + cobimetinib (C) + paclitaxel (P)/nab-paclitaxel (nP) as first-line (1L) treatment (tx) for patients (pts) with locally advanced or metastatic triple-negative breast cancer (mTNBC).

Adam Brufsky, Sung‐Bae Kim, Zanete Zvirbule et al. · Journal of Clinical Oncology · 2019 · 32 citations

Breast Oncology, Immunology, Pharmacotherapy +17